Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 7:42 PM
Ignite Modification Date:
2025-12-24 @ 7:42 PM
NCT ID:
NCT05739903
Brief Summary:
This Phase I clinical study is to evaluate the safety/tolerability and pharmacokinetics of DA-1229\_01 (5/1000 mg x1 tablets) at fasting state.
Study:
NCT05739903
Study Brief:
Protocol Section:
NCT05739903